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Aim:  Fungal rhinosinusitis in patients with chronic 
sinusal disease study. In the past decades, there has been 
an increase in fungal infections, and fungal rhinosinusitis 
(FRS) has been diagnosed more frequently. Knowing the 
fungal flora, its prevalence and symptomatic presentation in 
patients with chronic rhinosinusitis (CRS) will allow a better 
understanding of this disease, permitting a correct diagnosis, 
and treatment and formulating its prognosis. Study design: 
clinical retrospective with transversal cohort. Material and 
Method: 62 patients diagnosed with FRS were selected 
among 890 cases of CRS undergoing endoscopic surgery. We 
assessed clinical history otolaryngologic examination with nasal 
videoendoscopy, CT scan, microbiologic and histopatologic 
tests. Results: The prevalence of FRS was 6.7% and the fungal 
type most frequently found was the gender Aspergillus. 
Fungal ball was found in more than half the cases, and 
allergic fungal rhinosinusitis (AFRS) in more than one third 
of the patients. Evolution after endoscopic sinus surgery was 
more favorable in patients with fungus ball, with a minor 
number of recurrences. Conclusions: The symptomatic 
evolution following endoscopic surgery was more favorable 
in patients with fungal ball, who require a lower number of 
re-interventions.
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INTRODUCTION
Fungi are present in most ecosystems and there are 
over 20,000 species already identified. In the past two dec-
ades medicine has witnessed the increase in fungal infec-
tions in humans, caused by over 250 different species, as a 
result of the increase in use of immunosuppressant drugs 
for the treatment of cancer and control of transplanted 
organ rejection, infections by human immunodeficiency 
virus (HIV), diabetes mellitus, use of vascular and urinary 
catheters and use of broad spectrum antibiotics. From 
simple candidiasis to mortal aspergillosis, mycoses are 
frequently present in all levels of daily medical practice.
Fungal rhinosinusitis (FRS) has been referred in 
the medical literature for over two centuries. However, 
for the past 25 years it has received the due attention, 
with increase in diagnostic suspicion and improvement 
in laboratory techniques for detection of fungi. Its clas-
sification, based on immune relation between fungi and 
their host and level of mucosa invasion, is important in the 
selection of an effective treatment and for the definition of 
the prognosis. The knowledge of this type of fungal flora, 
its prevalence, symptomatic presentation, aspects of the 
physical examination and supplementary tests in patients 
with chronic rhinosinusitis (CRS) will enable better under-
standing of the disease, raising awareness of the involved 
physicians for appropriate diagnosis and treatment.
The present study was performed to define the 
prevalence of fungi infections in patients with CRS submit-
ted to surgical treatment, its classification according to FRS 
and clinical presentation followed by progression after the 
application of treatment.
PATIENTS AND METHODS
Study Design
The present study comprised a cohort of patients 
with CRS submitted to surgical approach of paranasal 
sinuses using endoscopic method, between January 1988 
and December 2002 in Porto Alegre, RS, with the diagno-
sis of FRS. The studied factors were the classification of 
patients and the outcome was their progression.
Criteria for inclusion and exclusion
We assessed 890 patients with CRS submitted to 
paranasal sinuses endoscopic surgical procedure and we 
selected 62 patients with diagnosis of FRS, confirmed by 
direct mycological and/or culture and/or clinical pathol-
ogy analysis.
We considered the patients with CRS and signs 
and symptoms of inflammation of paranasal sinuses that 
persisted for more than 12 weeks, associated with the 
documented affections by imaging techniques after at least 
4 weeks of appropriate clinical treatment1.
We excluded patients that did not agree to par-
ticipate in the study or sign the informed consent term, 
those that had not been postoperatively followed up for 
at least 6 months and those that did not meet the above-
mentioned criteria.
Method of sample collection
Middle meatus or paranasal sinuses secretions 
were collected unilaterally, under endoscopic view, with 
aspirator sterilized in autoclave at 2mm diameter coupled 
in a collection recipient Specimen Trap model 076-0490 
(Sherwood Medical, St. Louis, USA).
Patients’ assessment
Anamnesis - It comprised general clinical history 
and specific history directed to ENT affections by assess-
ing the following data: nasal obstruction, rhinorrhea, nasal 
pruritus, sneezing, post-nasal dripping, epistaxis, olfaction 
affections, oropharynx complaints, headache, hoarseness, 
cough, asthma, and expectoration.
Otorhinolaryngological examination - The exam 
included nasal videoendoscopy, performed by rigid endo-
scope of 4mm and 30° and 0° angle or 6mm flexible en-
doscope, under local anesthesia with cotton ball soaked in 
neotutocaine at 2% and vasoconstriction with oxymetazolin 
when necessary. We observed the following data: nasal 
septal deviation, aspect of medium and inferior turbines, 
mucosa color, presence and type of secretion, polyposis, 
polypoid degeneration and middle meatus status.
Radiological study - We performed paranasal si-
nuses CT scan, without intravenous contrast at axial and 
coronal plans, with patients in dorsal decubitus. Presence 
of microcalcifications and metallic density image inside 
the paranasal sinuses were considered as suggestive of 
presence of fungi2,3.
Microbiological exam - Clinical sample were col-
lected during the surgical procedure and placed in Stu-
art transportation medium (Starplex Scientific, Ontario, 
Canada) for the cultivation of aerobe microorganisms, in 
a broth of thioglycolate for the cultivation of anaerobes. 
The material was referred for analysis within 1 hour from 
collection.
For aerobe culture, the material was prepared 
in plaques containing agar medium McConkey (Difco, 
Detroit, USA or Becton Dickinson, Maryland, USA) and 
Triptycase Soy agar (Difco, Detroit, USA) enriched with 
10% goat blood (agar blood) and incubated at 37o C for 
24 hours. If there was no bacterial growth, the medium 
was reincubated for 24 hours more hours before it was 
released as negative.
The cultivation for anaerobe germs was performed 
through preparation in goat blood agar and the base was 
agar blood brucella (Difco, Detroit, USA) and bacteroid 
bile esculin agar, with incubation for up to 72 hours in 
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atmosphere of anaerobiosis provided by systems Gaspak 
(Becton Dickinson, Maryland, USA), Anaerocult (Merck 
SA, Brazil) or Anaerobac (Probac, Sao Paulo, Brazil). 
Thioglycolate broth was used as back up for cultivating 
anaerobes in case of suspicion of presence of germs in 
the sample (estimated by Gram method) and absence 
of plaque growth. After isolation and confirmation of 
anaerobe germ, the identification of the microorganism 
was made by using API system for anaerobe germs (Bio 
Merieux, France).
Mycological analysis was performed through direct 
material examination between the lamina and the laminula 
and the culture of the material in medium Sabouraud with 
or without cloramphenicol and cyclohexamide. Incubation 
was at 25o-35 C, and cultures were observed up to 20 days 
before release as negative for fungi. The identification of 
fungi and yeasts were made from microscopic morphology 
and use of commercial kit to identify the yeasts (Systems 
API, Bio-Merieux, France), respectively.
Histopathological exam - The samples of the mu-
cosa of the involved sinus, according to the histopatho-
logical findings were classified as:
a) nonspecific chronic inflammation (edema with 
thickness of mucosa lamina propria, lymphoplasmocytar-
ian infiltrate and perivascular fibrosis);
b) suppurative chronic inflammation (previous 
characteristics with neutrocytarian infiltrate);
c) allergic chronic inflammation (chronic inflamma-
tion with eosinophilic infiltrate);
d) chronic inflammation with fungal invasion 
(visualization of filamented and segmented hyphae with 
staining by PAS and Grocot methods).
Classification of patients
Patients were classified according to type of FRS, 
according to surgical and histopathological findings, such 
as fungal ball, saprophyte infection, invasive FRS, AFRS 
and indolent FRS, as provided by Ferguson criteria4:
a. fungal ball: characterized by entangled hyphae 
in the paranasal sinuses, without tissue invasion and mini-
mum mucosa inflammation reaction;
b. saprophyte infestation: asymptomatic presence of 
visible fungi in mucosa crusts of the nose or the paranasal 
sinuses, without mucosa invasion;
c. invasive fungal rhinosinusitis: fungal infection 
with tissue invasion at histopathological exam, with or 
without vascular invasion;
d. allergic fungal rhinosinusitis: presence of mucus 
with numerous eosinophils, Charcot-Leyden crystals, rare 
hyphae and mucosa inflammation reaction, without fungi 
invasion;
e. indolent or chronic invasive fungal rhinosinusitis: 
presence of fungi with absent or minimal vascular inva-
sion.
Patients’ follow up
The follow-up of patients was performed by the 
authors using anamnesis, complete ENT examination and 
nasal endoscopic exam. The follow-up was performed for 
a minimum of 6 months.
Statistical analysis
To compare the proportions, we used the chi-square 
test, with correction of Yates when the number was one, 
and Fischer exact test if the expected number for some 
specific characteristic was below 5 patients.
Symptoms were compared by using the score scale 
with t test for matched samples (parametric data) and T 
Wilcoxon test (non-parametric data for matched samples), 
and ANOVA (analysis of variance) for repetitive measure-
ments for mean comparisons.
For α = 0.05 and β = 0.20 and to identify the differ-
ences of exposure and control of at least 20% to 25%, we 
estimated a minimum sample size of 60 patients per group 
(total = 120). The acceptable error was 5% (p < 0.05).
The project was approved by the Research Ethics 
Committee of Hospital de Clínicas de Porto Alegre.
RESULTS
Out of a total of 890 nasosinusal surgical proce-
dures, we selected the cases in which we detected the 
presence of fungi identified by laboratory exams, which 
are the object of this study.
We analyzed the data of 62 patients (6.7%) with 
mean age of 40.6 years (ranging from 8 to 81 years, 
median of 45.4 years), 25 male and 37 female patients, 
without statistically significant difference (p = 0.13, t Stu-
dent test). Only one patient was Black, and all the others 
were Caucasian.
Signs and symptoms found are summed up in Table 
1. The duration of symptoms ranged from 3 months to 
over 5 years.
The most frequent comorbidities were rhinitis in 33 
patients (53.2%), bronchial asthma in 21 patients (33.8%), 
hypertension in 16 (25.8%), and aspirin intolerance in 14 
(22.5%). There were fewer cases of repetitive bronchop-
neumonia (7 patients), bronchiectasia (6 patients), hepatitis 
(4 cases), organ transplantation and primary immunode-
ficiency (3 patients), diabetes mellitus and leukemia (2 
patients) and isolated cases of cystic fibrosis, tuberculosis 
and hypophysis tumor. As to previous use of medication, 
59 patients (95.1%) had used broad-spectrum antibiotic in 
the month before the surgery, 37 (59.6%) had used topical 
nasal corticoids, 25 (40.3%) had used oral corticoids, and 
6 (9.7%) had received some type of immunosuppressant 
drugs that were not corticoids.
Only 11 patients (18.6%) had been previously sub-
mitted to nasosinusal surgery: 3 to endoscopic polypec-
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tomy, 4 to sinusotomy, 1 to septoplasty, 1 to rhinoplasty, 
1 to septoplasty and polypectomy and 1 to turbinectomy 
and sinusotomy.
Nasal endoscopic findings were: nasal secretion 
in 57 patients (91.9%), divided into 29 (46.7%) yellowish 
color, 23 (25%) greenish, 4 were brown and 1 was black; 
medium meatus obstruction in 47 (75.8), polyposis in 25 
(40.3%), bilateral in 10 (16.1%) and unilateral in 15 (24.1%), 
lower conchae hypertrophy in 17 (27.4%) and adenoid 
hypertrophy in 3 (4.8%).
All patients presented some type of opacification 
of paranasal sinuses CT scan and all other findings are 
listed in Table 2.
Mycological culture exam was obtained during sur-
gery and showed gender Aspergillus as the most frequent, 
followed by Candida and Penicilium (Table 3).
Bacteriological examination indicated associated 
bacterial infection in 47 patients with growth of S. aureus in 
15 cases (31.9%), P. aeruginosa in 10 (21.2%) and Haemo-
phillus sp. in 4 (8.5%). In 10 patients (16.9%) there was no 
bacterial growth and in 2 the exam was not performed.
Polypectomy was performed in 23 patients, in 6 
unilateral and in 17 bilateral cases.
Definite histopathological exam showed nonspe-
cific chronic inflammation in 25 cases (40.3%), allergic 
chronic inflammation in 21 cases (33.8%), suppurative 
chronic inflammation in 12 (19.3%), and fungal invasion 
in 4 (6.4%). As to FRS classification, we observed fungal 
ball in 33 patients (53.2%), AFRS in 24 (38.7%) and indo-
lent FRS in 3 (4.8%). In 2 patients, fungi were considered 
saprophyte. There was no case of invasive fungal rhinosi-
nusitis (Table 4).
Among the cases classified as fungal ball, nasal 
obstruction was present in 30 (90.9%), posterior nasal 
secretion in 29 (87.8%), and topical corticoids in only 9 
(27.3%). Cough was the complaint in 19 cases (57.5%), 
intolerance to aspirin was detected in only 1 case (3.5%) 
and 6 (18.2%) had repetitive pneumonia. Polyps were 
seen in only 2 cases (7.1%) and middle meatus obstruc-
tion in 7 (21.2%).
The patients with AFRS presented as a whole nasal 
obstruction, posterior nasal secretion and previous use of 
topical corticoids and systemic antibiotics. Cough was the 
complaint in 14 (58.3%) cases, 12 (50%) referred intoler-
ance to aspirin, and only 5 (20.1%) had previous pneu-
monia. Surgical findings evidenced multiple polyps in 22 
patients (19.6%), medium meatus obstruction in 21 (87.5%) 
and microcalcifications in 20 (81.8%) of the cases. The most 
frequent type of fungus was Aspergillus (8 cases).
Table 5 shows the comparison of preoperative find-
ings between these 2 groups.
There was no statistically significant difference when 
we compared mean age (p = 0.13, t Student test) and 
gender of the group with diagnosis of AFRS and fungal 
ball. Preoperative symptoms were statistically analyzed 
after placed in a scale and they were globally compared 
between the two diagnoses. The scores of the group using 
t test for independent samples did not show any difference 
between them (p= 0.715; CI 95%: -1.11 to 1.61).
Conversely, the use of topical corticoids, history of 
previous intolerance to aspirin and bronchial asthma, when 
Table 1. Preoperative clinical manifestation of studied 
patients.
Signs and symptoms n %
nasal obstruction 57 92
nasal secretion 55 89
post-nasal dripping 51 82
cough 43 69
allergic rhinitis 30 48
olfaction affections 21 34
asthma 21 34
sore throat 20 32
intolerance to aspirin 14 22
fatigue 14 22
facial pain 9 15
Table 2. CT scan findings.
  n %
Opacification 62 100,0
Middle meatus obstruction 49 79,0
Thickness or bone sclerosis 34 54,8
Microcalcifications 28 47,4
Metallic density images 18 29,0
Bone erosion 16 25,4
Sinus expansion 11 17,7
Table 3. Types of fungi identified in the mycological culture.
  n %
Aspergillus sp. 30 48,3
Candida sp 11 17,7
Penicillium 5 8,0
septated and ramified hyphae 5 8,0
Alternaria sp. 3 4,8
others 8 12,8
Table 4. Types of fungal rhinosinusitis.
  n %
Fungal ball 33 53,2
Allergic fungal rhinosinusitis 24 38,7
Indolent fungal rhinosinusitis 3 4,8
Saprophyte infection 2 3,2
Invasive fungal rhinosinusitis 0 - 
Total 62 100.0
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individually analyzed, were the only ones that showed 
statistically significant difference in the comparison of 
preoperative symptoms between the two groups, and it 
was more frequent in the patients with diagnosis of AFRS. 
The presence of polyps in the preoperative clinical exam 
in patients with RSFA (78.2%) was statistically greater 
(p<0.001, t Student test) than in the ones of fungal ball 
diagnosis (6.0%).
Comparing the radiographical studies with CT scan 
in both groups, the finding of obstruction of the middle 
meatus did not show statistically significant difference 
(chi-square test). The other findings, such as presence of 
bone erosion, were found in 12 patients (50%) with AFRS 
and in 4 (12.1%) with fungal ball (p<0.001), microcalcifica-
tion in 19 (79.1%) and 10 (30.3%) (p<0.001), and mucosa 
thickness in 8 (33.3%) and 2 (6.1%) patients (p = 0.02), 
respectively, evidencing a statistically significant difference 
between the groups.
As to type of fungus, we found there were no sta-
tistically significant differences in cultures.
Table 6 shows the comparison of surgical findings 
between the patients with diagnosis of fungal ball and 
those with AFRS.
Postoperative follow-up was on average 19.4 
months, with standard deviation of 6.3 months. Twenty 
patients (32.2%) were followed up for 6 months to 1 year, 
14 (22.6%) from 1 to 2 years, 6 from 3 to 4 years (9.7%), 7 
(11.2%) from 4 to 5 years, and 15 (24.2%) were followed 
up for more than 5 years.
General assessment of postoperative symptoms in 
all patients can be seen in Table 7.
In Table 8, we can evidence the significant symp-
tomatic improvement of the main complaints of patients 
with AFRS and fungal ball, comparing its presence pre 
and postoperatively.
When we compare the symptoms of both groups 
after the surgical procedure, using the same scale of scores, 
we evidence that the symptoms in patients with fungal ball 
are significantly smaller than the ones with AFRS, regard-
less of the test used. Parametric test (t test for matched 
samples) showed p < 0.0001 with CI 95% from 2.38 to 
3.89; in Wilcoxon t test (non-parametric test for matched 
samples) we found p < 0.0001, value that was repeated 
in ANOVA for repetitive measurements.
Sixteen patients (25.8%) presented recurrence and 
14 required surgical reintervention: 9 because of nasal 
polyposis, 4 because of fungal recurrence and 1 for puru-
lent rhinorrhea non-responsive to pharmacological treat-
ment. The interval between the primary surgical procedure 
and reintervention ranged from 10 months to 11 years.
Eleven patients (45.8%) with AFRS required surgical 
Table 5. Preoperative findings according to type of fungal 
rhinosinusitis.
Symptom Type of RFS Significance
  RSFA Fungal ball  
Nasal obstruction 100 91 NS*
posterior secretion 100 88 NS*
Topical corticoid 100 29 p<0,001**
Systemic Antibiotic 100 94 NS*
Allergic rhinitis 81 36 NS*
Asthma 77 11 p < 0,001**
Cough 58 57 NS*
Intolerance to AAS 50 3 p < 0,02**
Repetitive Bronchopneumonia 20 18 NS*
 p = Pearson p value for Chi-square test.
*NS - not significant (p > 0.05 )
** Yates correction of Chi-square
Table 6. Transoperative findings in cases of allergic fungal 
rhinosinusitis and fungal ball.
Transoperative findings RFS Type Significance
  RSFA Fungal ball  
Middle meatus obstruction 88 24  p < 0,001
Microcalcification 79 33  p < 0,02**
Polyps 91 6  p < 0,001*
 p = Pearson p value for Chi-square test.
* Fisher exact test
** Yates correction of Chi-square
Table 7. Postoperative assessment of symptoms.
  Asymptomatic Better Unaltered Worse
  n %  n %  n %  n %
Nasal obstruction 37  59,6  18  29,0   6  9,6  1 1,6
Postnasal dripping 32  51,6  22  35,4   6  9,6  2  3,2
Facial pressure 55  88,7  4  6,4  3  4,8  
Nasal secretion 31  50,0  23  37,1  6  9,6  2  3,2
Sore throat 51  82,2  10  16,1  1  1,6  
Facial pain 61  98,3  1  1,6    
Cough 43  69,3  11  17,7  4 6,4  2  3,2
Fatigue 55  88,7  5  8,1  2 3,3  
Altered olfaction 53  85,5  7  11,3  2  3,2  
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reintervention (Figure 7): 10 (41.6%) owing to recurrence 
of the disease and polyposis and one case because of 
contralateral disease. Only 3 patients (9%) with fungal ball 
required new surgery. The number of reinterventions was 
significantly higher (p < 0.002) in patients with AFRS than 
those with fungal ball.
As to use of postoperative drugs, 7 patients (11.2%) 
(3 indolent infections and 4 with AFRS) were treated with 
oral antifungal agents, 56 (90.3%) were treated with an-
tibiotics, and 55 (88.7%) were treated with nasal lavage 
with saline solution. For patients with AFRS, oral corticoids 
were prescribed for 83% of the patients and topical nasal 
corticoids were prescribed to 87.5%.
DISCUSSION
Approximately 300 species of fungi were docu-
mented as having caused diseases in human beings 5 and 
90% of the infections are attributed to few dozens of spe-
cies 6. Most fungi are exogenous, they exist in the soil, in 
water and organic debris. Most mycoses are caused by little 
fungi that are part of the normal flora, such as candidiasis, 
or are highly adapted to survive in the human body, such 
as dermatophytosis6.
FRS, despite being a little different, is a disease 
that produces significant morbidity, which may lead to 
death. Symptoms are easily overlapping with other situ-
ations, and it is difficult for the physician to recognize 
and, thus, diagnose it. Assessment and management of 
these conditions may require the participation of many 
specialists, including the otorhinolaryngologist, infectolo-
gist, microbiologist, and pathologist, providing appropriate 
diagnosis and treatment, preventing permanent sequelae 
and reducing mortality.
Incidence and prevalence of fungal infectious are 
growing with diversification of pathogenic organisms, 
as a result of the risk factors such as atopy in AFRS, dia-
betic ketoacidosis in mucomycosis and use of corticoids 
in candidiasis7. Impaired cell immunity in patients with 
AIDS also contributes to this growth, as all was in patients 
that use immunosuppressant or cytotoxic drugs to fight 
against neoplasm or to participate in programs for organ 
transplantation, which are getting more frequent in daily 
medical practice8.
The diagnosis of AFRS initially requires high de-
gree of suspicion by the physician, because the clinical 
history and the physical examination per se are rarely 
conclusive.
Schell9 considered important the presence of fungi 
in the middle meatus and paranasal sinuses so that we can 
respond to the difficult differentiations between coloniza-
tion and pathogenicity, and the laboratory methods that 
are adopted have to be as simple as possible, to that they 
are accessible in the daily medical routine.
The true incidence of FRS, especially AFRS among 
patients with CRS, remains unknown4. We demonstrated 
a prevalence of 6.7% of positive cultures for fungi in the 
series of patients with CRS submitted to surgical proce-
dures, a value greater than that found for Lessa et al.10 
(p<0.05, chi-square test) in a study performed in a public 
hospital in the city of Sao Paulo, which showed incidence 
of fungi in 31 patients (4.4%) of the 706 cases with CRS 
operated on between the years of 1995 and 2000. This 
difference in prevalence may be explained by our interest 
in identifying fungi, key objective of the study. Katzen-
stein et al.,11 in 1983, in the description of AFRS, found 
an incidence of 6.2%; Kupfenberg and Bent12 estimated 
that the fungus was the cause of 5% to 7% of the cases of 
CRS that required surgical treatment; and Yoon et al.,3 in 
South Korea, assessing 510 patients with CRS submitted 
to maxillary sinus surgery, found 39 (7.6%) cases of FRS 
histopathologically confirmed.
Quaraishi and Ramadan13 estimated the prevalence 
of fungi in 7%; Shubert14, in a bibliographical review of 
retrospective studies found values between 5 and 10%, 
coinciding with what was recorded by Houser and Corey15 
for patients with CRS with surgical indication.
Vennevald et al.16, however, had positive culture for 
fungi in 25.7% of the 117 immunosuppressed patients with 
non-invasive CRS submitted to paranasal sinuses endo-
scopic surgery, a fact that can be explained by the immune 
status of patients. Lebowitz et al.17, studied 45 patients with 
CRS submitted to endoscopic surgical procedures, isolated 
fungi in 56% of them using traditional laboratory methods, 
identical to employees that were routinely employed in the 
processing of samples for pulmonary secretion.
Because they are ubiquitous fungi, contamination 
of samples by the culture can occur easily during the col-
lection or laboratory processing. Considering the simple 
identification of fungi does not necessarily confirms the 
pathogenicity, the diagnosis of a mycotic infection can 
only be performed when we analyze the set of data of the 
culture, surgical findings and results of anatomopathologi-
Table 8. Progression of symptoms of patients with fungal ball 
and allergic fungal rhinosinusitis after surgical intervention.
  RSFA Fungal ball
  before after before after
nasal obstruction* 100 23 90 4
postnasal dripping* 100 23 84 10
nasal secretion* 95 23 97 10
sore throat* 77 14 58 13
cough* 68 9 13 -
Altered olfaction* 50 5 20 -
* p < 0.001 for chi-square test.
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cal exams.
Marple and Mabry5 pointed out the role of fungi 
in the development and perpetuation of infection in the 
upper airways and observed that the literature had strong 
evidence of allergic and non-allergic forms of non-invasive 
fungal inflammation. We still do not know if these forms 
of inflammation are independent or interrelated.
Published data in different studies are extremely 
varied when we analyze the species of fungi identified in 
patients with FRS. There is a large number of species and 
an important regional geographical variance of its preva-
lence. The most frequently reported genders are Aspergil-
lus, Alternatia, Candida, Penicilium, and Fusarium4,5,7.
We found species of Aspergillus in more than half 
of the samples described by Manning2, which consider this 
gender as predominant in cases of non-invasive FRS, a fact 
confirmed by Donald18 and Ruppa el al.19 Vennewald et al.16 
found Aspergillus sp. in 23 (67.4%) patients in a series of 
34 patients with FRS without affection of immune system 
and Kupfenberg20 in 19 (41.3%) in a series of 49 patients 
with the same pathology.
The incidence of a determined gender depends a 
lot on geographical and climatic conditions in which the 
patient lives, because the presence of a specific fungus in 
the environment is related with environmental conditions 
of temperature and air relative humidity4.
When identifying fungus as etiological agents of 
rhinosinusitis, it is important to classify them into type of 
FRS to be able to plan appropriate treatment and deter-
mine the diagnosis, which depends more on the response 
to host than to a specific type of fungus that causes the 
infection9. Initially, the response may be divides into two 
basic types: invasive and non-invasive, based on penetra-
tion of the fungus in the mucosa. Non-invasive FRS are 
diagnosed as fungal ball, saprophyte infestation or AFRS 
4. Among them, AFRS is the most controversial in the lit-
erature. The diagnostic criteria were initially proposed by 
Katzenstein11, with the presence of fungi without invasion 
of mucosa, mucus-thickness, eosinophilic inflammation 
and Charcot-Leyden crystals.
In the clinical presentation of patients with the di-
agnosis of FRS, the predominant symptoms that we found 
were nasal obstruction (92%), nasal secretion (88.7%), 
postnasal dripping (82.2%), and cough (69.35%), common 
to all patients with CRS, thus, it is not important in the 
suspicion or presence of fungi. The most frequent comor-
bidity in our series was allergic rhinitis (53.2%), practically 
the same incidence (62%) marked by Kalinger21 in a study 
with 200 consecutive patients with CRS that were seen by 
allergists or immunologists. The frequency of bronchial 
asthma (38.2%) is similar to that found by Manning2.
After surgical procedure, patients were classified 
based on type of FRS according to the criteria adopted 
by Ferguson4, based on surgical, microbiological and his-
topathological findings.
No occurrence of invasive RFS was identified in 
our series. Invasive RFS is a situation in which it affects 
people with severe associated diseases and the diagnosis 
is normally made in patients that are not hospitalized 4, 8. 
It always affects immunocompromised patients, patients 
with AIDS or those that take corticoids or immunosuppres-
sant drugs for the treatment of neoplasms or after organ 
transplantation. Diabetic patients in ketoacidosis have high 
risk for invasive disease caused by fungi in Zygomycetes, 
which prefer acid environment with high concentration 
of glucose. The absence of invasive RFS in our series can 
be explained by the origin of patients: they were all out-
patients who did not have severe diseases.
Based on these findings, we decided to concentrate 
on the study of these two groups that are more prevalent, 
fungal ball and AFRS, comparing the clinical and surgical 
findings and progression after treatment.
Upon comparing the age of the two groups we 
found a difference between them, despite the fact that the 
fungal ball is found in the literature as a situation in which 
the most advanced age patients are affected4,7,22.
Preoperative findings of patients with diagnosis of 
fungal ball, when compared to AFRS, did not show statisti-
cally significant difference concerning nasal secretion and 
obstruction, use of systemic antibiotics, history of allergic 
rhinitis, and repetitive bronchopneumonia. Patients with 
AFRS presented significantly greater number of bronchial 
asthma, intolerance to aspirin and use of topical corticoids, 
facts that may be explained by the presence of atopy in 
these patients. Ferguson22, in a literature review, had not 
found differences between the symptoms of patients with 
fungal ball when compared to patients that have other 
types of FRS.
The presence of polyps was statistically greater in 
cases of AFRS, data compatible with that reported by the 
authors Houser and Corey15, who found polyps in all pa-
tients with AFRS, and those by Ferguson22, who presented 
10% of patients with fungal ball. Those with AFRS also had 
bone erosion and thickness of mucosa that were signifi-
cantly greater. Houser and Corey15 described bone erosion 
in only 20% of the cases in a literature review.
After they had been individually analyzed, pre and 
postoperative data were statistically treated and included 
in a scale of values, enabling global comparison of symp-
tomatology between the two groups. This global com-
parison of symptoms did not show differences between 
them, a fact that was reported by Ferguson4, Houser and 
Corey15 and Manning7.
However, when these symptoms were individually 
compared, patients with AFRS presented more intolerance 
to aspirin, bronchial asthma, presence of nasal polyposis 
and previous use of topical corticoids. These 4 factors, 
similarly to AFRS, are known to be related to atopy, a 
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characteristic that may explain this difference.
The great difference in polyposis in patients with 
AFRS is compatible with the findings published in the liter-
ature, and their presence is normally reported as diagnostic 
criteria. Houser and Corey15 considered the incidence of 
polyps in practically 100% of the cases. Kupfenberg and 
Bent12, and Manning2 found polyps in all patients of their 
series, submitted to surgical treatment.
In patients with diagnosis of fungal ball, the pres-
ence of polyposis in 2 (6.1%) was similar to that found 
by Ferguson 22 (10%) in a bibliographical review of 158 
cases.
In the symptomatic assessment after the surgical 
procedure, we observed improvement in all items related 
with over 90% of the patients, confirming efficiency and 
benefit of the surgery, similar to the results obtained in 
patients of CRS23,24.
Using the same scale of values for symptoms, we 
observed significantly better symptomatic improvement 
in patients with fungal ball, who had fewer recurrences 
and required smaller number of reinterventions when 
compared to AFRS. These results evidenced the recurrent 
character and the severity of AFRS.
For patients with fungal ball, the level of recurrence 
(9%) is similar to that found by Ferguson22, estimated in 
the literature review as between 4% and 10%. Manning7 
and Kupfenberg20 considered that the recurrence of fungal 
ball is rare.
The number of recurrences of AFRS was much 
greater, and in 45.8% of them they required surgical reinter-
vention, marking the chronic and recurrent characteristic 
of the disease and its difficult control. The success of treat-
ment with AFRS depends on three steps: to make surgical 
debridment to remove fungal antigens, allergic mucin and 
affected polypoid mucosa; to prevent recurrence of fungal 
growth, and to modify the immune response of host to 
antigen. Given that we do not always get the appropriate 
control of allergic symptomatology, we can expect post-
operative follow-up with more recurrences.
The literature is quite controversial about the real 
role of fungi in CRS and we agree with most authors4,7,9,11,17 
that consider that the simple identification of the fungus 
is not enough for diagnosis, which should be performed 
together with surgical and clinical pathological findings.
There are few questions about the fact that fungi 
or their protein components may stimulate the respiratory 
tract through allergic mechanisms mediated by IgE. The 
literature offers much evidence that explain the allergic 
and non-allergic forms of non-invasive fungal infections. 
In the future, we should define how much these forms are 
interrelated or independent one from the other.
The understanding of immune mechanisms and the 
way through which we can interfere on them may increase 
the effectiveness of diagnoses and treatments, reducing the 
recurrence of the disease, especially in cases of AFRS.
Fungal infection is an emerging problem in daily 
clinical practice, and its prevalence has increased owing 
to a large number of chronic diseases resulting from aging 
of the population and/or from pathological situations that 
require use of drugs that affect the immune system.
In our study, we tried to define the prevalence of 
fungal infection in immunocompetent patients, as well as 
type of clinical presentation of the disease. The knowl-
edge of these facts is important in the clinical suspicion 
and investigative approach of ENT patients with CRS in 
our daily practice.
CONCLUSION
The prevalence of FRS was 6.7% in patients with 
CRS submitted to paranasal sinuses endoscopic surgery, 
with predominance of Aspergillus, including the significant 
amount of Candida, Penicilium and Alternaria.
The type of FRS most frequently detected was 
fungal ball in more than half of the cases, followed by 
AFRS, present in more than one third of the patients. The 
diagnosis of indolent FRS and saprophyte infection was 
not very frequent. The progression after endoscopic sur-
gery was more favorable in those with fungal ball, which 
required fewer interventions.
We suggest that new studies are performed to 
complement the one we had started especially with im-
munosuppressed patients and those with invasive disease, 
which were not included in our study.
The increase in our knowledge and understanding 
of the fungal disease will make us enhance our clinical 
suspicion, precision of diagnosis and effectiveness of treat-
ment, providing better prognosis to our patients.
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